Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025